Bioimpedance Analyzers Market Analysis and Forecast to 2031: By Product (Multi-frequency Analyzers, Single-frequency Analyzers, Dual-frequency Analyzers), Modality (Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers), Application (Whole-body Me

Bioimpedance Analyzers Market Analysis and Forecast to 2031: By Product (Multi-frequency Analyzers, Single-frequency Analyzers, Dual-frequency Analyzers), Modality (Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers), Application (Whole-body Measurement, Segmental Body Measurement), End User (Fitness Clubs and Wellness Centers, Home Users, Hospitals, Others), and Region

The global bioimpedance analyzer market size was USD 439 million in 2021 and it is anticipated to reach USD 1.375 billion in 2031, growing at a rate of 12.1% from 2022 to 2031.

Bioimpedance measuring devices are used to measure the level of fluids in living tissue. These devices use electrical conductivity and reactance, which is a property of an object that opposes any change in the electric current flowing through it. This type of device can provide vital information regarding fluid buildup or dehydration for athletes and those with chronic health conditions like heart diseases.

Bioimpedance Analyzers Market Scope and Structure Analysis

Market Trends and Drivers

Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of certain lifestyle diseases, like obesity, high blood pressure, and diabetes. According to WHO, in 2019, an estimated 38.2 million children under the age of 5 were overweight or obese. Once considered a high-income country problem, overweight and obesity are now on the rise in low- and middle-income countries, particularly in urban settings. In Africa, the number of overweight children under 5 who were overweight or obese in 2019 lived in Asia. Owing to that, the increasing prevalence of lifestyle diseases is boosting the growth of the global bioimpedance analyzers market.

Likewise, emerging economies such as India, China, and Brazil are likely to see high growth in the bioimpedance analyzers market. This can be attributed to the increasing prevalence of lifestyle diseases, growing awareness about health and obesity, and infrastructural improvements in these countries. China is a prominent market in this regard, given its recent infrastructural improvements, rapid economic growth, rising domestic demand, and public-private initiatives to support healthcare research. China’s State Council approved the 2016-2020 National Fitness Plan, which has motivated all national fitness levels and increased sports participation. Due to these factors, the global bioimpedance market is witnessing significant growth opportunities.

Market Restraints & Challenges

One of the primary challenges in the growth of the global bioimpedance analyzers market is inconsistency in the accuracy of different bioimpedance analyzers. Although the technology is improving, it is difficult to obtain accurate body fat measurements from most commercially available body fat analyzers. The working of analyzers comprises passing an electric current. However, a large amount of fat underneath the skin is not detected by these analyzers. Adding to that, body impedance varies among different ethnic groups and influences the accuracy of body composition analyzers.

Global Bioimpedance Analyzers Market Segmentation

The report analyses the bioimpedance analyzers market based on product, modality, application, end-user, and regions.

Global Bioimpedance Analyzers Market by Product

On the basis of type, it is segmented into multi-frequency analyzers, single-frequency analyzers, and dual-frequency analyzers. The multi-frequency analyzers segment is likely to dominate the market during the forecast period. Multi-frequency bioelectrical impedance analysis (MF-BIA) may be a relatively simple, quick method to measure body composition, for instance, fat mass and fat-free mass, having the advantage of being portable, relatively cheap, and not requiring specialist training for use. The growth of this segment can be attributed to the increasing preference for multi-frequency bioimpedance analyzers is high among end-users as they are both segmental and whole-body measurements, unlike single-frequency bioimpedance analyzers.

Global Bioimpedance Analyzers Market by Modality

Based on modality, it is segmented into wired bioimpedance analyzers, and wireless bioimpedance analyzers. The wired bioimpedance analyzers are likely to dominate the market during the forecast period. The key factors boosting the market growth are the increasing prevalence of lifestyle diseases coupled with initiatives by governments and private organizations to promote healthy lifestyles is boosting the growth of the segment in the market. The impedance analyzer measures the difference between the maximum current and the minimum current, but also the time difference between the potential and the current wave-forms.

Global Bioimpedance Analyzers Market by Application

By application, it is segmented into whole-body measurement and segmental body measurement. The demand in the bioimpedance market for segmental body measurement is expected to grow significantly in the forecast period. The whole-body measurement is expected to hold a significant share of the market due to the increasing prevalence of obesity and metabolic disorders. Thus, the demand in the bioimpedance market would rise during the forecast period.

Global Bioimpedance Analyzers Market by End User

By end user, it is divided into fitness clubs and wellness centers, home users, hospitals, and others. The demand for bioimpedance analyzers in fitness clubs and wellness centers is expected to grow significantly during the forecast period. The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are boosting the growth of the market.

Geographical Analysis of Global Bioimpedance Analyzers Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.

Major Players of the Global Bioimpedance Analyzers Market

The global bioimpedance analyzers market report includes players such as Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare, Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., Bodystat Ltd., Maltron International, Biotekna, Withings, Biodynamics Corporation, Akern, Xiaomi, Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd., Lumsail Industrial Inc., Guangzhou Beautylife Electronic Technology Co., Ltd., Bioparhom.

COVID-19 Analysis

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of bioimpedance analyzer producers have ceased. While some bioimpedance analyzers are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of obesity owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their medical device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for bioimpedance analyzers from wellness centers has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the bioimpedance market growth during the forecast period.

Recent Developments

• January 2022, Withings, introduced the Withings Body Scan, a novel smart scale at the Consumer Electronics Show. The scale comprises ECG capabilities via a series of electrodes and four weight sensors.
• August 2021, Samsung, introduced its latest ‘Galaxy Watch 4 Classic’ and Galaxy Watch 4’ in India. The company has included the body composition capability for the first time in this new series to revolutionize the smartwatch industry.
• June 2021, Seca, announced a strategic marketplace partnership with PointClickCare Technologies. Through the partnership, the companies plan to deliver a seamless integration that will improve provider and patient safety by tightly integrating to reduce the risk of data transfer, transcription and conversation errors, and costly time delays.
• January 2020, Inbody USA officially launched the InBody 970 at CES Las Vegas. The InBody 970, paired with the Yscope, uses new patented technology to analyze and categorize abdominal fat and total body water.
• May 2019, Fresenius Medical Care, announced that the company plans to invest around 60 million euros in Unicyte AG which is an independent affiliate of Fresenius Medical Care.

Bioimpedance Analyzers Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global bioimpedance analyzers market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
• A thorough analysis of aspects that boost and restrict the development of the market is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future bioimpedance analyzer market potential from 2021 to 2031 in terms of revenue.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global bioimpedance analyzers industry.

Frequently Asked QuestionsQ. How big is the Bioimpedance Analyzers market?Ans. The global Bioimpedance Analyzers market size was USD 439 million in 2021 and is anticipated to reach USD 1,375 million in 2031, growing at a rate of 12.1% from 2022 to 2031.Q. What is the Bioimpedance Analyzers market growth rate?Ans. The growth rate of the Bioimpedance Analyzers market is 12.1% from 2022 to 2031.Q. Which region holds a major market share for the Bioimpedance Analyzers market?Ans. North America holds a major market share of the Bioimpedance Analyzers market in 2021.Q. Which segment accounted for the largest Bioimpedance Analyzers market share?Ans. By end-user, the Fitness clubs and Wellness Centers segment accounted for the largest Bioimpedance Analyzers market shareQ. Who are the key players in the Bioimpedance Analyzers market?Ans. Omron Corporation, Tanita Corporation, InBody, RJL Systems, seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare, Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., Bodystat Ltd., Maltron International, Biotekna, Withings, Biodynamics Corporation, Akern, Xiaomi, Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd., Lumsail Industrial Inc., Guangzhou Beautylife Electronic Technology Co., Ltd., Bioparhom.Q. What are the factors driving the Bioimpedance Analyzers market growth?Ans. The major factors driving the growth of the market are the rise in prevalence of obesity & diabetes along with growth in investments for R&D activities in bioimpedance analyzers.Q. What are the key growth strategies of Bioimpedance Analyzers market players?Ans. The key growth strategies of Bioimpedance Analyzers market players are product launch and product approval.Q. Which region will provide more business opportunities for the Bioimpedance Analyzers market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for Bioimpedance Analyzers market during the forecast period

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.